Skip to content
+85256022027
0

Jimin Xpharma

  • Home
  • About us
  • News
  • Products
    • All Products
      • Suvotinib tablets
      • Spinraza(Nusinersen 12 mg/5 ml injection)
      • Nusinersen 12 mg/5 ml injection
  • Contact us
  • Shipping and Delivery
  • Refund Policy
  • Privacy Policy
Close Button

Home

Tablets

Suvotinib tablets

Tx of adult palients with locally advanced or metastatic Nsclc with EcFR exon 20 inserion lExon20ins mutationsApproved by the National Medical Products Administration (NMPA) of China

ALECENSA

ALECENSA is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene:

to help prevent your lung cancer from coming back after your tumor has been removed by surgery (adjuvant), or
as treatment when your lung cancer has spread to other parts of your body (metastatic)
Your doctor will perform a test to make sure that ALECENSA is right for you. It is not known if ALECENSA is safe and effective in children.

LIOTHYRONINE SODIUM

Liothyronine Sodium Tablets, USP are a thyroid hormone drug indicated:

As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis.
As pituitary thyroid-stimulating hormone (TSH) suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s) and multinodular goiter.
As diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy.

Injection

Nusinersen 12 mg/5 ml injection

Survival motor neuron-2 ($MN2)-directed antisense oligonucleotideFor tx. of spinal muscular atrophy (SMA) in pediatric and adult patients

ADUHELM

ADUHELM is indicated for the treatment of Alzheimer’s disease. ADUHELM should be started in patients with mild cognitive impairment or mild dementia stage of disease, the population studied in clinical trials. ADUHELM is approved under accelerated approval based on reduction in amyloid plaques as seen in patients treated with ADUHELM. Continued approval of ADUHELM may require verification of clinical benefit in a confirmatory study

AMVUTTRA

AMVUTTRA is a prescription medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). AMVUTTRA is used in adults only.

For additional information about AMVUTTRA, please see the full Prescribing Information.

Search

Archives

  • July 2025

Meta

  • Log in

Categories

  • 未分类

Jimin Xpharma. All Rights Reserved. By Themespride

WhatsApp us